This bonus issue features a look at the most recent changes to Maintenance of Certification programs, highlights from recent hematology/oncology meetings, and more.
This issue features a look at attaining gender inequality in medicine, refining patient-doctor communication, dealing with clinical trials–induced burnout, and more.
This issue features a look at gaining oral parity for cancer medications, the unavoidable "bubbles" in which people live and work, and more.
This issue features a look at the hidden costs of importing lower-cost drugs, the optimal hemophilia treatment, the limits of genetic testing, and more.
This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.
This issue features a look at the U.S. health-care system’s transition from a paper-based system to electronic health records, an introduction to a series about oncology nurse practitioners, and more.
This supplement features a look at controversies in myeloma treatment, the future of immunotherapy for lymphoma, newly approved and investigational therapies, and more.
This issue features a debate over whether CPX-351 can be used with other therapies in AML, a look at contract research organizations, and more.
This issue features a conversation with National Cancer Institute Director Norman “Ned” Sharpless, MD, a look at the prevalence and controversial nature of academic-industry partnerships, and more.
This issue features highlights from the 2017 ASH Annual Meeting, including a look at the first anti-sickling agent for sickle cell disease, and more.